RB

Robert E. Bellet

AS Aventis Pharma S.A.: 1 patents #304 of 591Top 55%
CP Cell Pathways: 1 patents #17 of 22Top 80%
Overall (All Time): #2,200,313 of 4,157,543Top 55%
2
Patents All Time

Issued Patents All Time

Patent #TitleCo-InventorsDate
6538029 Methods for treatment of renal cell carcinoma W. Thompson, John Fetter, Han Li 2003-03-25
6333348 Use of docetaxel for treating cancers Charles L. Vogel 2001-12-25